Vaccination with tumor cell lysate‐pulsed dendritic cells augments the effect of IFN‐β gene therapy for malignant glioma in an experimental mouse intracranial glioma

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Cancer

• Publication date

  2004-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.20331PMID 15252850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Gene Therapy for Malignant Gliomas (Glioblastoma Multiforme and Anaplastic Astrocytoma) by In Vivo Transduction with Human Interferon β Gene Using Cationic Liposomes

  2004cited by this paper
• Tumor-Infiltrating Lymphocyte Secretion of IL-6 Antagonizes Tumor-Derived TGF-β1 and Restores the Lymphokine-Activated Killing Activity1

  2004cited by this paper
• Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

  2003cited by this paper
• Immunotherapy and biological modifiers for the treatment of malignant brain tumors.

  2003cited by this paper
• Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-β gene vector and dendritic cells

  2003cited by this paper
• Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism.

  2002cited by this paper
• Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy

  2002cited by this paper
• NK cells are essential for effective BCG immunotherapy

  2001cited by this paper
• Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

  2001cited by this paper
• Potential of gene therapy for brain tumors.

  2001cited by this paper
• Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.

  2001cited by this paper
• IFN-β Gene Therapy Induces Systemic Antitumor Immunity Against Malignant Glioma

  2000cited by this paper
• IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

  2000cited by this paper
• Interferon‐β mediates stromal cell rescue of T cells from apoptosis

  1999cited by this paper
• Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

  1999cited by this paper
• Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?

  1999cited by this paper
• Interferon-beta mediates stromal cell rescue of T cells from apoptosis.

  1999cited by this paper
• Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse

  1999cited by this paper
• Strong cytotoxic T lymphocyte responses to a macrophage inflammatory protein 1alpha-expressing tumor: linkage between inflammation and specific immunity.

  1999cited by this paper
• Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

  1999cited by this paper
• Effect of human interferon β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells

  1998cited by this paper
• Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas

  1997cited by this paper
• Enhancement of Antitumor Immunity by CTLA-4 Blockade

  1996cited by this paper
• Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

  1996cited by this paper
• Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

  1996cited by this paper
• Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.

  1995cited by this paper
• Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors

  1995cited by this paper
• Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain.

  1994cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Cytotoxicity of human beta-interferon produced in human glioma cells transfected with its gene by means of liposomes.

  1992cited by this paper
• Antitumor Effect of Endogenous Human β-Interferon on Malignant Glioma and Augmentation of the Effect by Tumor Necrosis Factor-α

  1992cited by this paper
• Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene

  1991cited by this paper
• Properties of the novel proinflammatory supergene "intercrine" cytokine family.

  1991cited by this paper
• Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody.

  1990cited by this paper
• Growth Inhibition of Glioma Cells of Different Cell Lines by Human Interferon-β Produced in the Cells Transfected with Its Gene by Means of Liposomes

  1990cited by this paper
• Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

  1989cited by this paper

• Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy

  2025cites this paper
• Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma

  2024cites this paper
• Intestinal probiotic-based nanoparticles for cytotoxic siRNA delivery in immunotherapy against cancer.

  2024cites this paper
• Clinical implication of cellular vaccine in glioma: current advances and future prospects

  2020cites this paper
• Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme

  2015influential citation
• Overview of current immunotherapeutic strategies for glioma.

  2015cites this paper
• Immunocompetent murine models for the study of glioblastoma immunotherapy

  2014cites this paper
• Immunotherapies for Brain Cancer: From Preclinical Models to Human Trials

  2014cites this paper
• Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials

  2013cites this paper
• Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy

  2013cites this paper
• Curative one-shot systemic virotherapy in murine myeloma

  2012cites this paper
• Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies

  2012cites this paper
• High-Grade Gliomas: Dendritic Cell Therapy

  2011cites this paper
• Dendritic cell-based tumor vaccination for high-grade gliomas

  2011cites this paper
• Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model

  2011cites this paper
• Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy.

  2010cites this paper
• DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

  2009cites this paper
• Dendritic Cell Therapy of High‐Grade Gliomas

  2009cites this paper
• Persistence of CD133+ Cells in Human and Mouse Glioma Cell Lines: Detailed Characterization of GL261 Glioma Cells with Cancer Stem Cell-Like Properties

  2008cites this paper
• In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma

  2008cites this paper
• Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model.

  2007cites this paper
• Immunotherapy for brain tumors: quo vadis?

  2006cites this paper
• Cellules dendritiques et gliomes : un espoir en immunothérapie ?

  2006cites this paper
• [Dendritic cells and gliomas: a hope in immunotherapy?].

  2006cites this paper
• Genetic strategies for brain tumor therapy

  2006cites this paper
• Dendritic cell-based immunotherapy for malignant gliomas

  2005cites this paper
• T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.

  2005cites this paper
• Immunotherapy for malignant glioma: current approaches and future directions

  2005cites this paper
• Evaluation of IP-10 and TNFalpha-transducing parvoviral vectors as antitumoral agents in animal glioblastoma models

  2005cites this paper